He is also the Director of the National Pancreas and Islet Transplant Laboratories at Westmead Hospital. He is focused on the development of pancreatic islet transplantation as a mainstream therapy for patients with difficult to control Type 1 diabetes. His laboratory research is focused on the surgical models used for assessment of immunobiology of islet xenograft rejection and developing islet xenografts as a clinical therapy.